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1. Introduction 
The development of cardiovascular diseases is characterized by the loss of structural 
integrity of blood vessels that requires extensive remodeling of the extra-cellular matrix 
(Michel et al., 2011; Garcia-Touchard et al., 2005). The entire aorta and some medium-sized 
arteries have elastic properties and mechanical strength allowing these vessels to withstand 
a surge of blood ejected from the heart. Such properties of blood vessels are contributed 
mostly by two major components of the extracellular matrix: elastin and collagen (Barbour 
et al., 2007; Wagenseil & Mecham, 2009; Sawabe, 2010). Elastin fibers are responsible for the 
elastic properties and collagen fibers provide mechanical strength to the arterial wall 
(Arteaga-Solis et al., 2000). These two proteins have a fibrillar structure and in their mature 
forms are very resistant to proteolysis. Thus elastin has a half-life around 50 years 
(Wagenseil & Mecham, 2009). However in some pathological conditions, excessive 
proteolytic activity results in extracellular matrix breakdown that is a key factor of arterial 
wall damage and the development of potential rupture. Sites of atherosclerotic and 
aneurysmatic lesions are characterized by increased elasto- and collagenolytic activity 
(Diehm et al., 2007; Shimizu et al., 2006; Barbour et al., 2007; Sukhova et al., 1998). The 
dominant histological feature of aneurysmatic lesions is a chronic medial and adventitial 
inflammation resulting in medial degeneration and smooth muscle cell apoptosis. One of 
the most important contributors to aneurysmatic degeneration is an excessive loss of 
extracellular matrix. Fragmentation of elastin and collagen fibers is a characteristic feature of 
aneurysm formation and their loss is the ultimate cause of aneurysmatic rupture as well as 
rupture of atherosclerotic plaques (Shimizu et al., 2006; Sakalihasan et al., 2005; Diehm et al., 
2007). Recently it has been shown that together with some matrix metalloproteinases, 
cathepsin K, L and S are the primary proteolytic culprits responsible for the breakdown of 
extracellular matrix proteins in blood vessels (Abdul-Hussien et al., 2010; Rizas et al., 2009; 
Sukhova & Shi, 2006). Cysteine proteinases cathepsin K, L and S belong to the most potent 
elasto- and/or collagenolytic proteinases with potent abilities to degrade extracellular 
matrix. These enzymes attracted attention due to their upregulation within the aortic wall 
under different pathological conditions (Lutgens et al., 2007; Lafarge et al., 2010; Liu et al., 
2004). Their expression was revealed in macrophages, smooth muscle cells and endothelial 
cells in atherosclerotic and aneurismal lesions in humans. These results instigated a series of 
studies on the involvement of cathepsin K, L and S in the development of cardiovascular 
diseases based on animal models of atherosclerosis and abdominal aortic aneurysm  
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formation (Lutgens et al., 2007; Lafarge et al., 2010; Liu et al., 2004). The lack of these 
proteases resulted in a plaque size reduction and delay of plaque progression as well as in 
reduced level of medial elastin degradation and smooth muscle cell transmigration from the 
media to the intima (Lutgens et al., 2006a; Rodgers et al., 2006; Samokhin et al., 2008; 
Sukhova et al., 2003). These results were corroborated by in vitro experiments that revealed 
the differences in collageno- and elastolytic activities of smooth muscle cells and 
macrophages from mice expressing and lacking these cathepsins. 
The availability of specific cathepsin inhibitors allowed the conduction of in vitro and in vivo 
experiments that confirmed the involvement of cathepsins in aortic extracellular matrix 
destruction and atherosclerosis progression (Samokhin et al., 2010b) Immunostaining for 
cathepsin K revealed its high level of expression in multinucleated giant cells in human 
specimens from carotid arteries and abdominal aortic aneurysm as well as in mouse 
atherosclerotic plaques (Samokhin et al., 2010c; Chapman et al., 1997). High level of 
cathepsin K expression is a marker of active osteoclasts; in these giant cells cathepsin K is a 
major enzyme responsible for bone resorption (Bromme et al., 1996). Similarly, cathepsin K-
expressing giant cells were found close to damaged elastin laminae in aorta, suggesting an 
important role for this enzyme in the development of cardiovascular diseases (Samokhin et 
al., 2010c; Chapman et al., 1997). 
2. Extracellular matrix of the aortic wall 
Elastin and fibrillar collagen are the main components of the arterial wall responsible for its 
mechanical properties (Wagenseil & Mecham, 2009; Arteaga-Solis et al., 2000; Sawabe, 2010). 
Elastin is the major protein that confers elastic properties to the arterial wall. It is produced 
by smooth muscle cells of the tunica media in form of the soluble precursor tropoelastin and 
after polymerization by lysyl oxidase, forms interconnecting concentric rings around the 
arterial lumen. A high number of cross-links (15-20 per tropoelastin unit) is responsible for 
elastin insolubility, long half-life and resistance to proteolysis (Wagenseil  & Mecham, 2009; 
Arteaga-Solis et al., 2000; Sawabe, 2010). Elastin fibers are formed by elastin and associated 
microfibrils. Microfibrils form a scaffold for elastin polymerization and they are mainly 
composed of fibrillin and a collagen type IV (Sawabe, 2010; Pasquali-Ronchetti & Baccarani-
Contri, 1997). This three-dimensional network of interconnecting elastin fibers is designed to 
transfer stress throughout the arterial walls and is responsible for their dilation and recoil 
(Wagenseil & Mecham, 2009; Shadwick, 1999). The aortic wall is characterized by the 
abundant presence of elastic fibers associated with smooth muscle cells in the medial area 
(Barbour et al., 2007, Sakalihasan et al., 2005). Elastic fibers are also interconnected with 
collagen bundles (Wagenseil  & Mecham, 2009). 
Collagen is made up of a triple helix of three polypeptide chains. Types I, II and III collagens 
belong to ''fibrillar'' collagens that are the most abundant (van der Rest  & Garrone, 1991). 
Types I and III collagens provide tensile strength and maintain the structural integrity of the 
blood vessels. In aorta these two types of collagens are mostly found in media and 
adventitia (Wagenseil  & Mecham, 2009; Barbour et al., 2007; Sakalihasan et al., 2005). Types 
IV, V, and VI are nonfibrillar collagens highly present in the basement membrane. Fibrillar 
collagens type I and III are highly resistant towards proteolysis. They can be degraded only 
by specific collagenases that are able to cleave within the triple helix of native fibrillar 
collagen (Abdul-Hussien et al., 2007).  
Medial elastin and collagens types I and II in the media and adventitia determine much of 
the structural integrity and stability of arteries (Shimizu et al., 2006; Arteaga-Solis et al., 
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2000). The increased turnover of elastin and collagen results in aortic dilation and possible 
rupture (Shimizu et al., 2006). The fragmentation and loss of collagen and elastin fibers is 
one of the most important and consistent histological features of aneurismal changes in 
aorta (Dobrin  & Mrkvicka, 1994; Barbour et al., 2007). 
Because of the long half-life of collagen fibers and the extremely long half-life of elastin, loss 
of these two extracellular matrix proteins almost certainly results from increased 
degradation rather than decreased synthesis. Indeed, the predominant role of increased 
proteolysis is well described for the pathogenesis of aneurysm formation (Barbour et al., 
2007; Sakalihasan et al., 2005; Michel et al., 2011). Traditionally, matrix metalloproteinases 
were considered the main culprits in blood vessel extracellular matrix cleavage (Kadoglou & 
Liapis, 2004; Newby, 2008), whereas some recent data point out to the important role of 
cathepsin K, L and S in this pathological process (Chapman et al., 1997; Shimizu et al., 2006; 
Abisi et al., 2007).  
3. Cathepsin K, L and S are strong extracellular matrix-degrading enzymes 
Cathepsin K, L and S are lysosomal cysteine proteases of the papain family. These enzymes 
share many common features but also have significant differences in distribution, activity 
and corresponding physiological functions. Cathepsin K has the highest level of expression 
in osteoclasts and plays a major role in collagen turnover in bones (Bromme et al., 1996). 
This protease is also expressed at lower levels in macrophages, epithelial cells, fibroblasts, 
smooth muscle cells which can be elevated under pathological conditions (Chapman et al., 
1997). Thus, high cathepsin K concentration was found in rheumatoid arthritic joints, in 
epithelioid and multinucleated giant cells in lungs, and in thyroid glands (Buhling et al., 
2004; Samokhin et al., 2010a; Tepel et al., 2000). Cathepsin K is not detectable in normal 
blood vessels, but is highly expressed in macrophages, smooth muscle cells, endothelial and 
multinucleated giant cells in atherosclerotic lesions and in giant cell aortitis (Sukhova et al., 
1998; Platt et al., 2007; Chapman et al., 1997; Samokhin et al., 2010c). Cathepsin K is the most 
efficient elastinolytic enzyme (Bromme et al., 1996) and, in contrast to other cathepsins, has 
the ability to cleave triple-helical collagens both outside and inside the helical regions 
(Lecaille et al., 2008; Garnero et al., 1998). This unique feature enables cathepsin K to 
perform complete cleavage of collagens, a process that usually requires a cooperative action 
of several extracellular matrix-degrading enzymes.  
Cathepsin S is predominantly expressed in spleen and antigen-presenting cells, including B 
cells, macrophages, dendritic and epithelial cells (Chapman et al., 1997; Gupta et al., 2008). 
In these cells, cathepsin S plays an important role in the proteolytic degradation of the 
invariant chain, thus regulating antigen presentation to CD4+ T-cells by MHC II molecules 
(Honey & Rudensky, 2003; Hsing & Rudensky, 2005). In addition to its role in the immune 
response, cathepsin S can be secreted by such cells as macrophages, smooth muscle cells, 
endothelial cells and some tumor cells (Gupta et al., 2008) and plays an important role in 
extracellular matrix remodeling. Similarly to cathepsin K, cathepsin S shows strong 
collagenolytic and elastolytic activities and in contrast to cathepsin K and L, this protease is 
more stable and retains activity at neutral pH (Chapman et al., 1997; Taleb & Clement, 2007). 
Under pathological conditions, cathepsin S is upregulated in lung and blood vessel tissues 
and its stability at neutral pH may significantly contribute to the degradation of the 
extracellular matrix (Deschamps et al., 2010; Samokhin et al., 2011; Hirakawa et al., 2007; 
Williams et al., 2009). 
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Cathepsin L is ubiquitously expressed and similarly to cathepsin S, plays an important role 
in the immune system by degrading the invariant chain in MHC class II processing (Honey 
& Rudensky, 2003; Hsing & Rudensky, 2005). Mice lacking cathepsin L have epidermal 
hyperplasia with periodic hair loss, older animals develop dilative cardiomyopathy 
(Lankelma et al., 2010; Reinheckel et al., 2005). This enzyme is also involved in the 
development of kidney diseases in mice and humans and is upregulated in a variety of 
cancers (Reiser et al., 2010). Cathepsin L is a potent elastase (equivalent to cathepsin S) and 
collagenase (similar to cathepsin K) (Chapman et al., 1997). The physiological role of mouse 
cathepsins L is most likely replaced by cathepsin V in human tissues (Tolosa et al., 2003). 
A common feature of these cathepsins is their strong ability to degrade elastin and collagen 
fibers. Cathepsins have attracted attention as extracellular matrix-degrading enzymes only 
recently.  Previously it was assumed that they are inactive outside of cells due to their 
instability at neutral pH. However under pathological conditions, the acidification of the 
pericellular environment creates optimal conditions for lysosomal cathepsins. Thus, the 
destruction of elastin-rich arteries is associated with the accumulation of macrophages. In 
inflammatory conditions, macrophages secrete cathepsin K, L and S and at the same time 
increase expression of vacuolar-type H+-ATPase (Punturieri et al., 2000; Reddy et al., 1995). 
H+-ATPase acidifies the local environment and creates optimal conditions for cathepsin 
activities. Such increased expression of H+-ATPase has been revealed by 
immunohistochemical analysis in AAA in infiltrating monocytes and to a lesser extend in 
SMCs (Abdul-Hussien et al., 2010).  
In addition to their direct destructive role in blood vessel remodeling, cathepsins may 
promote the development of cardiovascular diseases by degrading lipoproteins and through 
their involvement in the regulation of apoptosis (Linke et al., 2006; Conus & Simon, 2008; 
Repnik & Turk, 2010). 
4. Increased expression of cathepsin K, L and S under pathological 
conditions in blood vessels 
4.1 Atherosclerosis 
Increased expression of cathepsin K and S in human atherosclerotic lesions was first described 
in 1998 (Sukhova et al., 1998). Until that time cathepsin K, L and S were already known as 
strong collagenases and elastases and researchers found a correlation between increased 
immunostaining for cathepsin K and S and increased elastase-degrading activity in 
atheromatous tissues extracts. The use of cathepsin and MMP inhibitors revealed that 
cathepsins had significantly greater contribution to elastolytic activity of atherosclerotic lesions 
extracts. Cathepsin K and S immunoreactivities were mostly localized in the fibrous cap region 
that suggested their important role in plaque destabilization (Sukhova et al., 1998; Rodgers et 
al., 2006). In addition, smooth muscle cells cultured with IFN- or interleukin-1 secreted 
active cathepsin S and showed significantly increased ability to degrade elastin. This elastolytic 
activity was abrogated by a selective cathepsin S inhibitor (Sukhova et al., 1998). In a similar 
experiment, a selective cathepsin S inhibitor or endogenous cathepsin inhibitor cystatin C 
significantly decreased SMC migration across an elastin gel (Cheng et al., 2006). In human 
atherosclerotic plaques cathepsins were localized in macrophages, SMCs and endothelial cells 
(Platt et al., 2007; Sukhova et al., 1998). The destructive role of cathepsin K in macrophage 
foam cells was confirmed by immunohistochemical analysis that revealed accumulation of 
collagen type I degradation products close to cathepsin K immunoreactivity. These results 
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were supported by an in vitro experiment where incubation of human macrophage foam cells 
on a collagen matrix resulted in the accumulation of collagen degradation products (Barascuk 
et al., 2010). Cathepsin K expression in endothelial cells in human atherosclerotic plaques also 
correlated with internal elastic lamina destruction (Platt et al., 2007). 
Similarly to cathepsin K and S, cathepsin L shows weak or no immunostaining in normal 
human arteries but its immunoreactivity increases significantly in atherosclerotic lesions 
and localizes in the fibrous cap and tunica media (Liu et al., 2006). Double immunostaining 
revealed that cathepsin L is mostly expressed in macrophages of the plaque shoulder 
regions, endothelial and smooth muscle cells. Serum cathepsin L level correlated with the 
development of atherosclerotic lesions (Liu et al., 2006). Furthermore, expression of 
cathepsin L correlated with apoptosis, formation of the necrotic core, decrease in collagen 
content and rupture of the fibrous cap (Li et al., 2009; Liu et al., 2006).  
4.2 Aortic aneurysm 
Increased expression of cathepsin K, L and S was found in abdominal aortic aneurysm and 
in popliteal artery aneurysm (Sukhova and Shi, 2006; Abdul-Hussien et al., 2010). Similarly 
to atherosclerosis, these enzymes were identified as major proteolytic culprits in abdominal 
aortic aneurysm and their expresion correlated with excessive collagen degradation (Abdul-
Hussien et al., 2007). The activities of cathepsin S and L were increased in abdominal aortic 
aneurysms and ruptured abdominal aortic aneurysms, whereas cathepsin K activity was not 
elevated despite a significant increase in the level of activated cathepsin K protein in aortic 
extracts (Abdul-Hussien et al., 2007; Abisi et al., 2007). Increased expression of cathepsin L 
in abdominal aortic aneurysm was localized in SMCs, Ecs and macrophages (Li et al., 2009). 
5. Studies of cathepsin K, L and S in mouse models of cardiovascular 
diseases 
5.1 Atherosclerosis 
The results of human studies prompted in vivo studies of the involvement of cathepsins in 
cardiovascular diseases using murine disease models. Apolipoprotein E- and low density 
lipoprotein receptor-deficient mice are widely used as animal models of atherosclerosis. These 
mice develop severe hypercholesterolemia and atherosclerosis similar to human 
atherosclerosis and atherosclerotic lesions progression can be accelerated by high fat diet. 
Firstly, the high expression of cathepsin L and S was shown in aorta of apolipoprotein E-
deficient mice. Immunohistochemical analysis showed positive staining for cathepsins L and S 
in the intima and within fibrous caps and cathepsin S was also detected in the medial area 
(Jormsjo et al., 2002). Soon after that, the effect of cathepsin S deficiency on atherosclerosis 
development was reported in experiments with low density lipoprotein receptor-deficient 
mice (Sukhova et al., 2003). Low density lipoprotein receptor-deficient mice lacking cathepsin 
S showed significant reduction of plaque size and area, preserved integrity of elastic lamina 
and reduced smooth muscle cell and collagen contents in the intima when compared to mice 
expressing cathepsin S. Absence of cathepsin S also resulted in decreased macrophage and 
leukocyte accumulation in atherosclerotic plaques (Sukhova et al., 2003). The atheroprotective 
effect of cathepsin S deficiency was also confirmed by experiments with apolipoprotein E-
deficient mice lacking this protease. (Rodgers et al., 2006). Atherosclerotic lesions in 
brachiocephalic arteries of apolipoprotein E-deficient and cathepsin S double deficient mice 
were significantly smaller and had fewer acute plaque ruptures. These mice also had a lower 
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number of buried fibrous caps, which are believed to be a marker of unstable atherosclerotic 
plaques. The fibrous caps in plaques of double knockout mice were also thicker compared to 
cathepsin S-expressing mice that most likely rendered higher stability to those plaques 
(Rodgers et al., 2006). Recently, the role of cathepsin S in atherosclerosis was investigated in 
chimeric low density lipoprotein receptor-deficient mice lacking this protease in leukocytes (de 
Nooijer et al., 2009). The absence of cathepsin S in leukocytes did not change the lesion size but 
reduced the necrotic core and changed plaque morphology. Chimeric mice contained more 
macrophages and less intimal smooth muscle cells and collagen. The lower number of intimal 
smooth muscle cells correlated with the marked decrease in the number of elastin lamina 
ruptures providing evidence for an important role of leukocyte-derived cathepsin S in elastin 
lamina disruption in atherosclerosis (de Nooijer et al., 2009). 
The role of cathepsin K in atherosclerotic lesions development was investigated in 
apolipoprotein E-deficient mice (Lutgens et al., 2006b; Samokhin et al., 2008; Lutgens et al., 
2006a).  Cathepsin K deficiency reduced the total plaque area in the aortic arch of mice 
receiving normal diet (Lutgens et al., 2006a) as well as the plaque size in the brachiocephalic 
artery after 16 weeks of high fat diet (Samokhin et al., 2008). In both experiments mice 
lacking cathepsin K had a smaller number of elastin lamina ruptures and increased collagen 
content compared to cathepsin K-expressing mice. Cathepsin K-deficient mice on normal 
diet had a borderline significant decrease in plaque macrophage content but the individual 
size of macrophages was increased and showed increased lipid uptake (Lutgens et al., 
2006b). Atherosclerotic plaques in the brachiocephalic artery of mice on high fat diet had a 
significant decrease in their macrophage content and an increase in collagen content after 8 
weeks of high fat diet. Smooth muscle cell loss in medial area was significantly lower in 
cathepsin K-deficient mice after 16 weeks of high fat diet that correlated well with the 
decreased number of elastin lamina breaks (Samokhin et al., 2008). Atherosclerotic plaques 
in brachiocephalic arteries had thicker fibrous caps and a smaller number of buried fibrous 
caps in cathepsin K-deficient mice. Similarly to cathepsin S, the effect of cathepsin K 
deficiency in leukocytes was studied in chimeric low density lipoprotein receptor-deficient 
mice (Guo et al., 2009). Leukocytes cathepsin K deficiency did not affect the plaque size but 
decreased elastin lamina fragmentation as well as collagen content and increased plaque 
macrophage content and the necrotic area. The effect of cathepsin L deficiency was studied 
on low density lipoprotein receptor-deficient mice (Kitamoto et al., 2007). Double knockout 
mice developed reduced atherosclerotic lesions with smaller lipid core compared to 
cathepsin L-expressing mice. They also had a lower number of elastin lamina ruptures and a 
decreased amount of plaque macrophages, CD4+ T-cells, smooth muscle cells and collagen. 
In in vitro experiments, cathepsin L-deficient smooth muscle cells showed delayed 
transmigration through an elastin layer, whereas cathepsin L-deficient monocytes and 
lymphocytes demonstrated reduced ability to migrate through collagen type I and IV coated 
transwell membranes. Based on these results, authors suggested that cathepsin L plays a 
significant role in medial smooth muscle cells and blood-borne leukocytes migration during 
development of atherosclerotic lesions (Kitamoto et al., 2007).  
5.2 Aortic aneurysm 
Increased expression of cathepsin K, L and S in blood vessels have been shown in several 
animal models of aneurysm induction. Cathepsin K and S were upregulated in a porcine 
model of abdominal aortic aneurysm (Sadek et al., 2008) and cathepsin L showed increased 
expression in a rabbit model of elastase-induced saccular aneurysm (Kadirvel et al., 2004). 
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The role of cathepsin K in aneurysm formation was investigated in a mouse model of 
aneurysm induction (Bai et al., 2010). Surprisingly, cathepsin K deficiency did not prevent 
aneurysm formation after angiotensin II infusion. Cathepsin K-lacking mice had the same 
aneurysm size and severity. The absence of cathepsin K did not prevent elastin degradation, 
whereas the collagen content was significantly increased in the aneurysm area in cathepsin 
K-lacking mice (Bai et al., 2010). 
6. Cathepsin inhibitors in the prevention of pathological aortic remodeling 
The highly destructive potential of cysteine cathepsins requires their tight regulation and one 
of such restrictive mechanisms is a presence of cathepsin inhibitors. Cystatin C is the most 
important inhibitor of cysteine cathepsins. It is a small protein expressed in virtually all organs 
and found in high concentration in biological fluids including blood (Shi et al., 1999). Cystatin 
C is present in normal blood vessels but its concentration significantly decreases in 
atherosclerotic and aneurismal lesions (Lindholt et al., 2001). Serum cystatin C level inversely 
correlated with abdominal aortic diameter in patients with abdominal aortic aneurysm (Shi et 
al., 1999). Animal experiments have shown that lack of cystatin C expression in apolipoprotein 
E-deficient mice results in more advanced atherosclerotic lesions with increased elastin lamina 
degradation and higher macrophage content (Bengtsson et al., 2005; Sukhova et al., 2005). In 
an angiotensin II-induced model of abdominal aortic aneurysm such mice showed aggravated 
destruction of elastin, increased cathepsin activity, fewer number of smooth muscle cells in 
tunica media and increased macrophage content and number of CD4+ T cells (Schulte et al., 
2010). Recently cathepsin K, L and S attracted a lot of attention as a potential therapeutic target 
in cardiovascular, bone and cartilage diseases (Turk, 2006; Bromme & Lecaille, 2009). The 
atheroprotective effect of a potent and selective cathepsin S inhibitor was tested in 
apolipoprotein E-deficient mice (Samokhin et al., 2010b). Animals receiving high fat diet 
containing the cathepsin S inhibitor developed significantly smaller plaques in brachiocephalic 
arteries, had smaller number of elastin ruptures, and lower levels of macrophages in plaques. 
Mice treated with cathepsin S inhibitor also showed a reduced number of buried fibrous caps 
providing evidence of more stable plaques. In this study, the cathepsin S inhibitor was also 
tested in peritoneal macrophages where cells showed reduced elastolytic activity (Samokhin et 
al., 2010b). This study also revealed some gender-related differences in atherosclerotic lesions 
development in response to inhibitor treatment. Female mice showed an almost 2-fold greater 
reduction in plaque sizes compared to the male group. The effectiveness of the cathepsin S 
inhibitor was verified by the build-up of intermediate invariant chain breakdown products in 
spleen. Cathepsin S plays an important role in MHC class II-associated antigen presentation by 
participating in proteolytic processing of invariant chain and its inhibition results in 
accumulation of invariant chain breakdown products (Honey & Rudensky, 2003). The 
inhibition of cathepsin S reflected most of the phenotype observed in experiments with 
cathepsin S-deficient mice  (Sukhova, 2003; Rodgers, 2006)  suggesting the high specificity of 
the inhibitor and the potential feasibility of the treatment of atherosclerosis with cathepsin 
inhibitors. 
7. Cathepsin K is highly expressed in multinucleated giant cells in aortic wall 
The presence of multinucleated giant cells within the aortic wall is described in giant cell 
arteritis and atherosclerosis. In these two diseases, multinucleated giant cells are formed by 
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the fusion of macrophages in inflammatory infiltrates of the arterial wall (Weyand et al., 
2005; Eberhardt & Dhadly, 2007; Soilleux et al., 2002). It was shown by 
immunohistochemical analysis and in situ hybridization that multinucleated giant cells from 
different organs and from patients with different pathological conditions have strong 
cathepsin K expression (Buhling et al., 2001; Chapman et al., 1997).  
7.1 Multinucleated giant cells in human atherosclerotic plaques show strong staining 
for cathepsin K 
The analysis of atherosclerotic plaques from carotid arteries and lesions from patients with 
abdominal aortic aneurisms revealed the presence of multinucleated giant cells  (Fig. 1). 
Similarly to giant cells arteritis, they were mostly localized in the media-intima junction 
(Samokhin, 2010c). The lesions contained Langhans-type multinucleated giant cells 
recognizable by their circular arrangement of nuclei and foreign body-type giant cells with 
random arrangement of nuclei.  
 
 
Fig. 1. Multinucleated giant cells in atherosclerotic lesions from carotid artery (trichrome 
staining, x10, asterisks show multinucleated  giant cells). 
Immunohistochemical analysis revealed strong expression of cathepsin K in multinucleated 
giant cells (Fig. 2). These results suggest an important role of cathepsin K from 
multinucleated giant cells in aortic wall damage in atherosclerosis and abdominal aortic 
aneurisms.  
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Fig. 2. Cathepsin K-positive multinucleated giant cells in atherosclerotic lesions from carotid 
artery (red – cathepsin K, blue - nuclei, x20, asterisks show multinucleated giant cells). 
7.2 Multinucleated giant cells in mouse atherosclerotic plaques 
Apolipoprotein E-deficient mice on cholate-containing high fat diet developed 
atherosclerotic lesions containing multinucleated giant cells (Fig. 3). These giant cells were 
observed in atherosclerotic plaques within the brachiocephalic artery and the aortic root and 
were easily detectable by intensive cathepsin K immunostaining (Samokhin et al., 2010c). 
They were mostly localized in the fibrous cap region and close to the elastin laminae. The 
presence of multinucleated giant cells correlated with the disruption of elastin fibers (Fig. 4) 
and the absence of smooth muscle cells within the tunica media. Similarly, in giant cell 
arteritis, multinucleated giant cells have been implicated in internal elastic laminae damage 
and their presence strongly correlated with smooth muscle cell migration (Kaiser et al., 1999; 
Penn & Dasgupta, 2003; Nordborg & Nordborg, 2003).  
Cathepsin K plays a major role in the destructive potential of osteoclasts and is suggested as 
a marker of macrophage differentiation (Brömme et al., 1996; Buhling et al., 2001). In 
contrast to macrophages, multinucleated giant cells in atherosclerotic lesions of 
apolipoprotein E-deficient mice do not show strong immunostaining for cathepsin L and S 
(Samokhin; 2010c). These results suggest that cathepsin K plays a crucial role in the 
destructive potential of multinucleated giant cells in the aortic wall.  
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Fig. 3. Cathepsin K immunostaining of atherosclerotic lesions in brachiocephalic artery of 
ApoE-/- mice (red- cathepsin K, green – elastin fibers autofluorescence, blue – nuclei, x20, 
asterisk shows multinucleated giant cell). 
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Fig. 4. Cathepsin K-positive multinucleated giant cell at the site of an elastin fiber break 
(red- cathepsin K, green – elastin fibers autofluorescence, blue- nuclei, x63). 
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Fig. 5. Predominant accumulation of elastin-FITC complexes on/inside of multinucleated 
giant cell (olive green – phalloidin-FITC, neon green – elastin-FITC, blue nuclei, x20). 
The involvement of cathepsin K in the increased elastolytic potential of multinucleated giant 
cells was further supported by an in vitro experiment where peritoneal macrophages were 
incubated with IL-4 to induce fusion and multinucleated giant cell formation. The fusion of 
macrophages resulted in dramatic increase in their elastolytic activity as was revealed by the 
cleavage of FITC-labeled elastin. On the third day of macrophage fusion, cells from 
cathepsin K-deficient mice showed a 30% reduction in their elastolytic activity compared to 
cells derived from cathepsin K-expressing animals (Samokhin, 2010c). Notably, most of the 
elastin fibers were attached to or engulfed by MGCs (Fig. 5) demonstrating that the 
observed increase in elastolytic activity was due to the process of giant cell formation.  
8. Conclusion 
The results of recent studies in humans and animal models provide evidences for the pivotal 
roles of cathepsin K, L and S in aortic extracellular matrix remodeling during pathological 
conditions. Their elasto- and/or collagenolytic activities render them into main culprits of 
matrix destruction observed in cardiovascular diseases and make these proteases attractive 
pharmaceutical targets for therapeutic interventions. 
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